BioSpace News Archive

BioCentriq, Inc announced today that they’ve completed a study designed to test transfection of T-cells with GFP mRNA for evaluation of cell viability, transfection efficiency, and post transfection growth using Kytopen’s Flowfect® technology.

Smart Radar Systems (SRS) announced its health monitoring system built on Interactor’s no-code API AutoFlow and showcased the solution during CES 2023.

Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has approved its Proclaim™ XR spinal cord stimulation (SCS) system to treat painful diabetic peripheral neuropathy (DPN), a debilitating complication of diabetes.

Unilabs, a leading diagnostic services provider, and Ambry Genetics, a leader in clinical diagnostic testing and a subsidiary of REALM IDx, have entered an exclusive partnership to enhance high-quality genetic testing services for government-sponsored and biopharma companies conducting international clinical trials and research.

Know Labs, Inc. Names Ron Erickson Chief Executive Officer; Former CEO Phil Bosua Becomes a Technology Consultant to the Company.

Syros Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation to tamibarotene for the treatment of higher-risk myelodysplastic syndrome (HR-MDS).

Emergent Health Corp. (OTC PINK:EMGE), a curator, developer and marketer of products in the Regenerative Health Space announced today that it has executed a Letter of Intent to acquire Nanosthetic Corp.

OpGen, Inc. and OpGen subsidiary, Ares Genetics (Ares) announced today the granting of a key patent by the China National Intellectual Property Administration (CNIPA).

Agenus today announced that Dr. Garo Armen, Chairman and CEO, and Dr. Steven O’Day, Chief Medical Officer, will participate in the following upcoming investor conferences.

Sun Nuclear, a wholly-owned subsidiary of Mirion Technologies, Inc., announced that it has designated Scripps Health as a Patient Safety Center of Excellence.